The relationship of presenting symptom burden and survival in patients with head and neck cancer (HNC)

被引：0
|
作者：
Gunn, G. B. [1 ]
Mendoza, T. R. [1 ]
Wang, X. S. [1 ]
Garden, A. S. [1 ]
Lewin, J. S. [1 ]
Morrison, W. H. [1 ]
Frank, S. J. [1 ]
Chambers, M. S. [1 ]
Cleeland, C. S. [1 ]
Rosenthal, D. I. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.5600
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5600
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Perceived Symptom Experience in Head and Neck Cancer Patients with Lymphedema
    Deng, Jie
    Ridner, Sheila
    Rothman, Russell
    Murphy, Barbara
    Sherman, Kerry
    Moore, Lee
    Hall, Kourtney
    Weiner, Betsy
    JOURNAL OF PALLIATIVE MEDICINE, 2016, 19 (12) : 1267 - 1274
  • [42] Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer
    Markus Hecht
    Dennis Hahn
    Philipp Wolber
    Matthias G. Hautmann
    Dietmar Reichert
    Steffi Weniger
    Claus Belka
    Tobias Bergmann
    Thomas Göhler
    Manfred Welslau
    Christina Große-Thie
    Orlando Guntinas-Lichius
    Jens von der Grün
    Panagiotis Balermpas
    Katrin Orlowski
    Diethelm Messinger
    Karsten G. Stenzel
    Rainer Fietkau
    BMC Cancer, 20
  • [43] Symptom burden in head and neck cancer: impact upon oral energy and protein intake
    Ganzer, Heidi
    Touger-Decker, Riva
    Parrott, James S.
    Murphy, Barbara A.
    Epstein, Joel B.
    Huhmann, Maureen B.
    SUPPORTIVE CARE IN CANCER, 2013, 21 (02) : 495 - 503
  • [44] Symptom Burden and Quality of Life in Long-Term Survivors with Head and Neck Cancer
    Gostian, Magdalena
    Allner, Moritz
    Rak, Atina
    Balk, Matthias
    Rupp, Robin
    Ostgathe, Christoph
    Mantsopoulos, Konstantinos
    Sievert, Matti
    Iro, Heinrich
    Hecht, Markus
    Gostian, Antoniu-Oreste
    ENT-EAR NOSE & THROAT JOURNAL, 2024,
  • [45] Assessment of clinical utility of angiogenesis and hypoxia markers in patients with head and neck cancer (HNC)
    Mrochem-Kwarciak, Jolanta
    Wygoda, Andrzej
    Rutkowski, Tomasz
    Chmura, Aleksandra
    Deja, Regina
    Skladowski, Krzysztof
    ORAL ONCOLOGY, 2021, 118
  • [46] Validation of a new swallow specific tool in a subset of head and neck cancer (HNC) patients
    Dwivedi, R.
    St Rose, S.
    Roe, J.
    Khan, A.
    Bisase, B.
    Nutting, C.
    ORAL ONCOLOGY, 2011, 47 : S29 - S30
  • [47] Symptom burden in head and neck cancer: impact upon oral energy and protein intake
    Heidi Ganzer
    Riva Touger-Decker
    James S. Parrott
    Barbara A. Murphy
    Joel B. Epstein
    Maureen B. Huhmann
    Supportive Care in Cancer, 2013, 21 : 495 - 503
  • [48] Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer
    Hecht, Markus
    Hahn, Dennis
    Wolber, Philipp
    Hautmann, Matthias G.
    Reichert, Dietmar
    Weniger, Steffi
    Belka, Claus
    Bergmann, Tobias
    Goehler, Thomas
    Welslau, Manfred
    Grosse-Thie, Christina
    Guntinas-Lichius, Orlando
    von der Gruen, Jens
    Balermpas, Panagiotis
    Orlowski, Katrin
    Messinger, Diethelm
    Stenzel, Karsten G.
    Fietkau, Rainer
    BMC CANCER, 2020, 20 (01)
  • [49] Assessment of clinical utility of angiogenesis and hypoxia markers in patients with head and neck cancer (HNC)
    Mrochem-Kwarciak, Jolanta
    Wygoda, Andrzej
    Deja, Regina
    Rutkowski, Tomasz
    Polanowski, Pawel
    Skladowski, Krzysztof
    ORAL ONCOLOGY, 2021, 118
  • [50] Prospective assessment of diurnal variation of Xerostomia in treated head neck cancer (HNC) patients
    Agarwal, S.
    Doshi, A.
    Patel, R.
    Roy, M.
    Kalyani, N.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S954 - S955
12345